Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Tiny nerve zaps may boost blood flow down there

NCT ID NCT04384172

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This small study tested whether mild nerve stimulation could increase vaginal blood flow in women with sexual problems, spinal cord injury, or no issues at all. Nine women had a small sensor placed in the vagina to measure blood flow changes during stimulation. The goal was to understand how nerves affect blood flow, not to treat any condition.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

9 people

The number who actually took part.

Started

Nov 2020

Finished

Mar 2022

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Non-dysfunction participants, no spinal cord injury Inclusion Criteria: * Adult (over 18 years old) cis-gender female * Neurologically stable * Sexually active at least once per month * Able to consent and communicate effectively with research team Exclusion Criteria: * Male * Pregnancy or planning to become pregnant during study period * Sexual dysfunction, per short-form Female Sexual Function Index (FSFI) score below 19 * Lubrication difficulties, per short-form FSFI lubrication subdomain score below or equal to 4 * Clinically diagnosed bladder dysfunction, pelvic pain, or other pelvic organ symptoms * Suspected or diagnosed epilepsy * Active infection or active pressure sores in the perineal region * Implanted pacemaker, defibrillator, spinal cord stimulator, or other nerve stimulator * Currently has or tested positive in the last 14 days for COVID-19 or is symptomatic for COVID-19. Sexual dysfunction participants, non- spinal cord injury Inclusion Criteria: * Adult (over 18 years old) cis-gender female * Neurologically stable * Sexually active at least once per month * Sexual dysfunction, per short-form FSFI score below 19 * Lubrication difficulties, per short-form FSFI lubrication subdomain score below or equal to 3 * Able to understand consent and communicate effectively with research team Exclusion Criteria: * Male * Pregnancy or planning to become pregnant during study period * Clinically diagnosed bladder dysfunction, pelvic pain, or other pelvic organ symptoms * Active infection or active pressure sores in the pelvic region * Implanted pacemaker or defibrillator * Currently has or tested positive in the last 14 days for COVID-19 or is symptomatic for COVID-19. Sexual dysfunction participants with spinal cord injury Inclusion Criteria: * Adult (over 18 years old) cis-gender women * Clinically diagnosed spinal cord injury (AIS A-B) at vertebral level within C6-T10 at least six months prior or clinically diagnosed spinal cord injury (AIS C) at vertebral level within C4-T10 at least six months prior * Nominally sexually active, but at minimum interest in sexual pleasure even if fully self-induced * Sexual dysfunction, per short-form FSFI score below 19 * Able to understand consent and communicate effectively with research team Exclusion Criteria: * Male * Spinal cord injury at or above C5 level (C1-C5) if AIS A or B, or spinal cord injury at or above C3 level (C1-C3) if AIS C * Spinal cord injury below T10 vertebral level or reflexes not preserved * Acute worsening in motor or sensory function in the last month * Suspected or diagnosed epilepsy * Pregnancy or planning to become pregnant during study period * Active infection or active pressure sores in the perineal region * Implanted pacemaker or defibrillator * Currently has or tested positive in the last 14 days for COVID-19 or is symptomatic for COVID-19.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Female sexual dysfunction are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Michigan

    Ann Arbor, Michigan, 48109, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.